GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Other Current Payables

Noxopharm (ASX:NOX) Other Current Payables : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Other Current Payables?

Noxopharm's Other Current Payables for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Noxopharm's quarterly Other Current Payables increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.27 Mil) but then declined from Jun. 2023 (A$0.27 Mil) to Dec. 2023 (A$0.00 Mil).

Noxopharm's annual Other Current Payables increased from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.99 Mil) but then declined from Jun. 2022 (A$0.99 Mil) to Jun. 2023 (A$0.27 Mil).


Noxopharm Other Current Payables Historical Data

The historical data trend for Noxopharm's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Other Current Payables Chart

Noxopharm Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Current Payables
Get a 7-Day Free Trial - - - 0.99 0.27

Noxopharm Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.99 - 0.27 -

Noxopharm Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Noxopharm Other Current Payables Related Terms

Thank you for viewing the detailed overview of Noxopharm's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Noxopharm (ASX:NOX) Business Description

Traded in Other Exchanges
Address
60 Linksley Ave, Glenhaven, NSW, AUS, 2156
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines